Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis.
about
Adenosine receptors as therapeutic targetsTargeting of adenosine receptors in ischemia-reperfusion injury.Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationA3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion.Mechanisms of induction of adenosine receptor genes and its functional significance.Sustained adenosine exposure causes lung endothelial apoptosis: a possible contributor to cigarette smoke-induced endothelial apoptosis and lung injury.A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis.Pharmacological enhancement of neuronal survival.The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis ratsLung injury after in vivo reperfusion: outcome at 27 hours after reperfusionProtective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury.The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Pulmonary Endothelial Cell Apoptosis in Emphysema and Acute Lung Injury.Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation.Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
P2860
Q24632095-768326D6-8870-4DC0-9960-C8734312D6E5Q30429069-0C307E82-4969-4F95-90C3-CD5652AC5DE0Q30431277-F6885032-5EFA-455B-A185-71EFE381D9CEQ30439172-A5EA0DC3-08DB-480C-883C-6DFCEBFB809AQ34999497-E9B40EDC-A176-4DE2-B8E8-68EACFDBE3DFQ35692398-6122DA4B-EB54-4A03-B8BB-F40FA8176DB3Q36699988-3BE44118-85CD-492E-96C8-2568C75C2B17Q36980497-9A2989BE-670F-490C-8F86-2FE27C29B104Q37146138-52C2506C-CBFF-43A4-BB27-2067BC36D3A1Q37180330-14778B12-F2EF-47BB-8E7A-ED8A47ADB88CQ37208124-925AEA23-8EDE-42E7-8F97-3D272C7EB24AQ37629304-074E7136-65CB-4E40-AD95-C417507D9528Q37957791-EE5F1329-43F4-4D43-BACF-9B96606B4A41Q47243831-676738BA-2785-46F2-AAD2-B25C5F5F7236Q53563061-0C33D64E-9496-4CD1-9A71-1CCFFB3297CEQ54397580-A5714804-CC54-44A0-98D6-1D7C0F64CB17
P2860
Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@en
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@nl
type
label
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@en
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@nl
prefLabel
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@en
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@nl
P2093
P2860
P1476
Activation of A3 adenosine rec ...... d with reduction in apoptosis.
@en
P2093
Evelyne Zeira
Idit Matot
Julia Rivo
P2860
P304
P356
10.1111/J.1600-6143.2004.00620.X
P407
P50
P577
2004-12-01T00:00:00Z